Get the Stockscreener App
61.84
1.87%
-1.18
State Street Spdr S P Pharmaceuticals Etf stock is traded at $61.84, with a volume of 241.46K.
It is down -1.87% in the last 24 hours and down -7.41% over the past month.
See More
Previous Close:
$63.02
Open:
$63.29
24h Volume:
241.46K
Relative Volume:
1.06
Market Cap:
$448.36M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-4.35%
1M Performance:
-7.41%
6M Performance:
+7.64%
1Y Performance:
+28.81%
1-Day Range:
$61.60
$63.30
1-Week Range:
$61.60
$64.61
52-Week Range:
$47.60
$74.34
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
61.84 | 448.36M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
701.61 | 1.03T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
766.67 | 879.75B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
763.25 | 806.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
374.07 | 688.96B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
709.80 | 474.71B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
Stock Market Research, Data and Tools - GuruFocus
Better Pharma ETF: iShares IHE vs. State Street XPH - The Motley Fool
Better Pharma ETF: iShares IHE vs. State Street XPH - The Globe and Mail
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Motley Fool
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Globe and Mail
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Zacks Investment Research
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Execution of Pharma Tariffs Brings These ETFs Into Focus - TradingView
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals - The Globe and Mail
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals - The Motley Fool
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals - Yahoo Finance
State Street SPDR S&P Transportation ETF (XTN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
SPDR S&P Biotech ETF (XBI) stock price, news, quote and history - Yahoo Finance UK
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
State Street SPDR S&P Biotech ETF (XBI) stock price, news, quote and history - Yahoo Finance Singapore
State Street SPDR S&P Insurance ETF (KIE) Stock Price, News, Quote & History - Yahoo! Finance Canada
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Health Care Services ETF (XHS) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Retail ETF (XRT)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)? - Yahoo Finance
Comparing Healthcare ETFs: Broad vs. Focused Exposure - Intellectia AI
IXJ vs XPH: Global Healthcare ETF or Pharma Focus? - The Motley Fool
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - tradingview.com
Broad Coverage or Concentrated Bets? Analyzing the Differences Between Healthcare Funds VHT and XPH - nai500.com
IXJ vs XPH: Global Healthcare ETF or Pharma Focus? - Yahoo Finance
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - The Motley Fool
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - The Motley Fool
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? - The Motley Fool
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - Yahoo Finance
ETFs Investing in ANI Pharmaceuticals, Inc. Stocks - tradingview.com
Ditch These Historic ETF September Underperformers - Finviz
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) rated B... - Pluang
XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI) - Seeking Alpha
Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense - Barron's
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
ETFs Investing in Ligand Pharmaceuticals Incorporated Stocks - TradingView
State Street SPDR S&P/ASX 200 Listed Property ETF Reports Daily NAV Update for September 2, 2026 - Kalkine Media
State Street SPDR S&P/ASX 200 ETF Announces Daily NAV and Fund Update for September 1, 2026 - Kalkine Media
Should You Invest in the State Street SPDR S&P Homebuilders ETF (XHB)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Eastern Progress
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - AOL.com
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - The Motley Fool
Healthcare ETFs Are Looking Up: Here's Why - cnhinews.com
Healthcare ETFs Are Looking Up: Here's Why - TradingView
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):